AbCellera Biologics Statistics
Total Valuation
ABCL has a market cap or net worth of $3.36 billion. The enterprise value is $2.96 billion.
| Market Cap | 3.36B |
| Enterprise Value | 2.96B |
Important Dates
The last earnings date was Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ABCL has 306.61 million shares outstanding. The number of shares has increased by 1.74% in one year.
| Current Share Class | 306.61M |
| Shares Outstanding | 306.61M |
| Shares Change (YoY) | +1.74% |
| Shares Change (QoQ) | +0.82% |
| Owned by Insiders (%) | 22.83% |
| Owned by Institutions (%) | 32.26% |
| Float | 206.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 50.83 |
| Forward PS | 111.26 |
| PB Ratio | 3.75 |
| P/TBV Ratio | 4.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 44.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.77, with a Debt / Equity ratio of 0.15.
| Current Ratio | 12.77 |
| Quick Ratio | 11.23 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -17.30% and return on invested capital (ROIC) is -42.28%.
| Return on Equity (ROE) | -17.30% |
| Return on Assets (ROA) | -10.39% |
| Return on Invested Capital (ROIC) | -42.28% |
| Return on Capital Employed (ROCE) | -17.95% |
| Weighted Average Cost of Capital (WACC) | 10.38% |
| Revenue Per Employee | $117,740 |
| Profits Per Employee | -$292,982 |
| Employee Count | 562 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -32.11M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +156.91% in the last 52 weeks. The beta is 1.19, so ABCL's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | +156.91% |
| 50-Day Moving Average | 6.51 |
| 200-Day Moving Average | 4.58 |
| Relative Strength Index (RSI) | 82.76 |
| Average Volume (20 Days) | 8,596,190 |
Short Selling Information
The latest short interest is 48.32 million, so 15.76% of the outstanding shares have been sold short.
| Short Interest | 48.32M |
| Short Previous Month | 45.11M |
| Short % of Shares Out | 15.76% |
| Short % of Float | 23.42% |
| Short Ratio (days to cover) | 8.29 |
Income Statement
In the last 12 months, ABCL had revenue of $66.17 million and -$164.66 million in losses. Loss per share was -$0.55.
| Revenue | 66.17M |
| Gross Profit | -131.60M |
| Operating Income | -225.16M |
| Pretax Income | -196.77M |
| Net Income | -164.66M |
| EBITDA | -192.56M |
| EBIT | -225.16M |
| Loss Per Share | -$0.55 |
Balance Sheet
The company has $540.10 million in cash and $135.62 million in debt, with a net cash position of $404.49 million or $1.32 per share.
| Cash & Cash Equivalents | 540.10M |
| Total Debt | 135.62M |
| Net Cash | 404.49M |
| Net Cash Per Share | $1.32 |
| Equity (Book Value) | 896.02M |
| Book Value Per Share | 2.92 |
| Working Capital | 626.04M |
Cash Flow
In the last 12 months, operating cash flow was -$94.94 million and capital expenditures -$24.73 million, giving a free cash flow of -$119.67 million.
| Operating Cash Flow | -94.94M |
| Capital Expenditures | -24.73M |
| Depreciation & Amortization | 25.20M |
| Net Borrowing | 29.73M |
| Free Cash Flow | -119.67M |
| FCF Per Share | -$0.39 |
Margins
Gross margin is -198.88%, with operating and profit margins of -340.27% and -248.84%.
| Gross Margin | -198.88% |
| Operating Margin | -340.27% |
| Pretax Margin | -297.37% |
| Profit Margin | -248.84% |
| EBITDA Margin | -291.00% |
| EBIT Margin | -340.25% |
| FCF Margin | n/a |
Dividends & Yields
ABCL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.74% |
| Shareholder Yield | -1.74% |
| Earnings Yield | -4.90% |
| FCF Yield | -3.56% |
Analyst Forecast
The average price target for ABCL is $17.13, which is 56.15% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.13 |
| Price Target Difference | 56.15% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | -32.57% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ABCL has an Altman Z-Score of 1.83 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.83 |
| Piotroski F-Score | 4 |